Clinomic was founded in 2019 and develops innovative healthcare solutions for critically ill patients by combining translational medical research, data science, artificial intelligence, and computational intelligence. The company focuses on patient-centric technologies that support optimized treatment and clinical decision-making in intensive care and critical care environments. By integrating advanced medical research with modern digital technologies, Clinomic aims to improve patient outcomes and enable more personalized and data-driven healthcare for critically ill individuals.